SUMMARY ANSWER: Pregnant women with hereditary thrombophilia have an increased
risk of RPL, especially for pregnant women with the G1691A mutation of the factor V Leiden …

Growing evidence suggests that thrombophilia is associated with venous thromboembolism
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …

Fetal growth restriction (FGR) is defined as the failure of the fetus to meet its growth potential
due to a pathological factor, most commonly placental dysfunction. Worldwide, FGR is a …

Objective To provide evidence to support updated guidelines for the management of
pregnant women with hereditary thrombophilia in order to reduce the risk of a first venous …

Background Our aim was to assess the strength of the controversial association between
thrombophilia and fetal loss, and to examine whether it varies according to the timing or …

В доступной форме в книге изложены основные события, произошедшие в
медицинской генетике и в молекулярной медицине после расшифровки генома …

Pre-eclampsia is more than pregnancy induced hypertension. The emerging view described
in this presentation is that pre-eclampsia is secondary to the interactions of reduced …

Background Factor V Leiden (FVL) and prothrombin gene mutation (PGM) are common
inherited thrombophilias. Retrospective studies variably suggest a link between maternal …

This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Background Recurrent pregnancy loss (RPL) is a significant clinical problem. Recently,
thrombophilias have been implicated as a possible cause. Factor V Leiden (FVL) and …